Related references
Note: Only part of the references are listed.The potential impact of tumour biology on improved clinical practice for medulloblastoma: progress towards biologically driven clinical trials
Barry L. Pizer et al.
BRITISH JOURNAL OF NEUROSURGERY (2009)
A New Model for Prediction of Drug Distribution in Tumor and Normal Tissues: Pharmacokinetics of Temozolomide in Glioma Patients
Lula Rosso et al.
CANCER RESEARCH (2009)
Efficacy of temozolomide for recurrent embryonal brain tumors in children
Chung-Hao Wang et al.
CHILDS NERVOUS SYSTEM (2009)
Vasoactivity of AG014699, a Clinically Active Small Molecule Inhibitor of Poly(ADP-ribose) Polymerase: a Contributory Factor to Chemopotentiation In vivo?
Majid Ali et al.
CLINICAL CANCER RESEARCH (2009)
Inhibition of Poly (ADP-Ribose) Polymerase-1 Enhances Temozolomide and Topotecan Activity against Childhood Neuroblastoma
Rachel A. Daniel et al.
CLINICAL CANCER RESEARCH (2009)
Analysis of microsatellite instability in medulloblastoma
Marta Viana-Pereira et al.
NEURO-ONCOLOGY (2009)
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.
Peter C. Fong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Medulloblastoma: new insights into biology and treatment
B. Pizer et al.
ARCHIVES OF DISEASE IN CHILDHOOD-EDUCATION AND PRACTICE EDITION (2008)
Phase I Study of the Poly (ADP-Ribose) Polymerase Inhibitor, AG014699, in Combination with Temozolomide in Patients with Advanced Solid Tumors
Ruth Plummer et al.
CLINICAL CANCER RESEARCH (2008)
Mechanisms of disease: temozolomide and glioblastoma - look to the future
Maciej M. Mrugala et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2008)
Phase I trial of single-dose temozolomide and continuous administration of O6-benzylguanine in children with brain tumors:: a Pediatric Brain Tumor Consortium report
Alberto Broniscer et al.
CLINICAL CANCER RESEARCH (2007)
Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors - A report from the children's oncology group
H. Stacy Nicholson et al.
CANCER (2007)
Therapeutic potential of drugs to modulate DNA repair in cancer
Nicola Curtin
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
ABT-888, an orallyactive poly(ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models
Cherrie K. Donawho et al.
CLINICAL CANCER RESEARCH (2007)
The blood-brain barrier and cancer:: Transporters, treatment, and Trojan horses
John F. Deeken et al.
CLINICAL CANCER RESEARCH (2007)
Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial
Huw D. Thomas et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Safety and pharmacokinetics of temozolomide using a dose-escalation, metronomic schedule in recurrent paediatric brain tumours
S. Baruchel et al.
EUROPEAN JOURNAL OF CANCER (2006)
Role of temozolomide in pediatric brain tumors
Giuseppe Barone et al.
CHILDS NERVOUS SYSTEM (2006)
Combined genome-wide allelotyping and copy number analysis identify frequent genetic losses without copy number reduction in medulloblastoma
JA Langdon et al.
GENES CHROMOSOMES & CANCER (2006)
Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair-deficient malignant glioma xenograft
CL Cheng et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Temozolomide pharmacodynamics in patients with metastatic melanoma: DNA damage and activity of repair enzymes 6-alkylguanine alkyltransferase and poly(ADP-ribose) polymerase-1
ER Plummer et al.
CLINICAL CANCER RESEARCH (2005)
Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors
P Jagtap et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Novel poly(ADP-ribose) polymerase-1 inhibitor, AG14361, restores sensitivity to temozolomide in mismatch repair-deficient cells
NJ Curtin et al.
CLINICAL CANCER RESEARCH (2004)
Anticancer chemosensitization and radiosensitization by the novel poly(ADP-ribose) polymerase-1 inhibitor AG14361
CR Calabrese et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Rational approaches to discovery of orally active and brain-penetrable quinazolinone inhibitors of poly(ADP-ribose)polymerase
K Hattori et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: The European Organization for Research and Treatment of Cancer Brain Tumor Group study 26971
MJ van den Bent et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Temozolomide for recurrent high-grade glioma
DR Macdonald
SEMINARS IN ONCOLOGY (2001)
Share Paper
